Takeda announced that the Food and Drug Administration (FDA) has approved Dexilant (dexlansoprazole) delayed-release capsules and Dexilant SoluTab delayed-release orally-disintegrating tablets for ...

Takeda Pharmaceuticals’ Dexilant SoluTab delayed-release orally disintegrating tablets received FDA approval. 1. The tablets are a new formulation of dexlansoprazole that can be taken by allowing the ...

HAYWARD, Calif. — Generic drug maker Impax Labs is hoping to become the first to market a version of a gastroesophageal reflux disease treatment made by Takeda Pharmaceutical. Impax said Tuesday that ...

Takeda announced that it has updated the product labeling for Dexilant (dexlansoprazole) to include information demonstrating that Dexilant had no clinically important effect on exposure to the active ...

DEERFIELD, Ill., April 26 Takeda Pharmaceuticals North America, Inc. today announced that DEXILANT(TM) (dexlansoprazole) delayed release capsules are now available in United States (U.S.) pharmacies.

Six months after Walgreens and three other retailers brought an antitrust lawsuit against Takeda and TWi Pharmaceuticals over an alleged “reverse payment” scheme, CVS has filed a similar antitrust ...

DEERFIELD, Ill., Nov. 17, 2011 /PRNewswire/ -- Today, Takeda Pharmaceuticals North America, Inc., (Takeda) announced the DEXILANT (dexlansoprazole) product labeling now includes information from a ...

TWi Pharmaceuticals, Inc. ("TWi") today announced that it has entered into a Settlement Agreement with Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A., Inc., Takeda ...

Please provide your email address to receive an email when new articles are posted on . Takeda has announced that the FDA approved its Dexilant SoluTab delayed-release formulation of the proton pump ...